Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

p53 mediates Bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway

Abstract

A member of the small G protein family, cdc42, was isolated from a screen undertaken to identify p53-inducible genes during apoptosis in primary baby rat kidney (BRK) cells transformed with E1A and a temperature-sensitive mutant p53 using a PCR-based subtractive hybridization method. Cdc42 is a GTPase that belongs to the Rho/Rac subfamily of Ras-like GTPases. In response to external stimuli, Cdc42 is known to transduce signals to regulate the organization of the actin cytoskeleton, induce DNA synthesis in quiescent fibroblasts, and promote apoptosis in neuronal and immune cells. In this study, we have demonstrated that cdc42 mRNA and protein were up-regulated in the presence of wild-type p53 in BRK cells, followed by cytoplasmic to plasma membrane translocation of Cdc42. Overexpression of Cdc42 in the presence of a dominant-negative mutant p53 induced apoptosis rapidly, indicating that Cdc42 functions downstream of p53. Furthermore, stable expression of a dominant-negative mutant of Cdc42 partially inhibited p53-mediated apoptosis. The Bcl-2 family members Bcl-xL, and the adenovirus protein E1B 19K, inhibited Cdc42-mediated apoptosis, whereas Bcl-2 did not. We provide evidence that PAK1 and JNK1 may play a role downstream of Cdc42 to transduce its apoptotic signal. Cdc42/PAK1 activates JNK1-induced phosphorylation of Bcl-2, thereby inactivating its function, and that a phosphorylation resistant mutant (Bcl-2S70,87A,T56,74A) gains the ability to inhibit Cdc42- and p53-mediated apoptosis. Thus, one mechanism by which p53 promotes apoptosis is through activation of Cdc42 and inactivation of Bcl-2.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Aspenstrom P, Lindberg U and Hall A. . 1996 Curr. Biol. 6: 70–75.

  • Bagrodia S, Dérijard B, Davis RJ and Cerione RA. . 1995 J. Biol. Chem. 270: 27995–27998.

  • Bazenet CE, Mota MA and Rubin LL. . 1998 Proc. Natl. Acad. Sci. USA 95: 3984–3989.

  • Benard V, Bohl BP and Bukoch GM. . 1999 J. Biol. Chem. 274: 13198–13204.

  • Blagosklonny MV, Schulte T, Nguyen P, Trepel J and Neckers LM. . 1996 Cancer Res. 56: 1851–1854.

  • Boivin D and Beliveau R. . 1995 Am. J. Physiol. 269: F180–F189.

  • Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR and Kley N. . 1995 Nature 377: 646–649.

  • Burbelo PD, Drechsel D and Hall A. . 1995 J. Biol. Chem. 270: 29071–29074.

  • Chiou S-K, Rao L and White E. . 1994 Mol. Cell. Biol. 14: 2556–2563.

  • Chou JJ, Li H, Salvesen GS, Yuan J and Wagner G. . 1999 Cell 96: 615–624.

  • Chuang TH, Hahn KM, Lee JD, Danley DE and Bukoch GM. . 1997 Mol. Biol. Cell 8: 1687–1698.

  • Coso OA, Chiariello M, Yu J-L, Teramoto H, Crespo P, Xu N, Miki T and Gutkind JS. . 1995 Cell 81: 1137–1146.

  • Debbas M and White E. . 1993 Genes Dev. 7: 546–554.

  • Deng X, Ruvolo P, Carr B and May JWS . 2000 PNAS 97: 1578–1583.

  • Dharmawardhane S, Sanders LC, Martin SS, Daniels RH and Bukoch GM. . 1997 J. Cell. Biol. 138: 1265–1278.

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.

  • Fuchs SY, Fried VA and Ronai Z. . 1998 Oncogene 17: 1483–1490.

  • Furukawa Y, Iwase S, Kikuchi J, Terui Y, Nakamura M, Yamada H, Kano Y and Matsuda M. . 2000 J. Biol. Chem. 275: 21661–21667.

  • Gille H, Strahl T and Shaw P. . 1995 Curr. Biol. 5: 1191–1200.

  • Gross A, McDonnell JM and Korsmeyer SJ. . 1999 Genes Dev. 13: 1899–1911.

  • Gulbins E, Coggeshall KM, Brenner B, Schlottmann K, Linderkamp O and Lang F. . 1996 J. Biol. Chem. 271: 26389–26394.

  • Gupta S, Campbell D, Derijard B and Davis R. . 1995 Science 267: 389–392.

  • Haldar S, Jena N and Croce C. . 1995 Proc. Natl. Acad. Sci. USA 92: 4507–4511.

  • Hall A. . 1998 Science 279: 509–514.

  • Han J, Sabbatini P, Perez D, Rao L, Modha D and White E. . 1996 Genes Dev. 10: 461–477.

  • Hu MC-T, Qiu WR and Wang Y-P. . 1997 Oncogene 15: 2277–2287.

  • Johnson DI. . 1999 Microbiol. Mol. Biol. Rev. 63: 54–105.

  • Ko LJ and Prives C. . 1996 Genes Dev. 10: 1054–1072.

  • Korsmeyer SJ. . 1995 Trends Genet 11: 101–105.

  • Levine AJ. . 1997 Cell 88: 323–331.

  • Manser E, Leung T, Salihuddin H, Tan L and Lim L. . 1993 Nature 363: 364–367.

  • Maundrell K, Antonsson B, Magnenat E, Camps M, Muda M, Chabert C, Gillieron C, Boschert U, Vial-Knecht E, Martinou JC and Arkinstall S. . 1997 J. Biol. Chem. 272: 25238–25242.

  • May WS, Tyler PG, Ito T, Armstrong DK, Qatsha KA and Davidson NE. . 1994 J. Biol. Chem. 269: 26865–26870.

  • McCurrach ME, Connor TMF, Knudson CM, Korsmeyer SJ and Lowe SW. . 1997 Proc. Natl. Acad. Sci. USA 94: 2345–2349.

  • McDonnell JM, Fushman D, Milliman CL, Korsmeyer SJ and Cowburn D. . 1999 Cell 96: 625–634.

  • McGlade CJ, Tremblay ML and Branton PE. . 1989 Virology 168: 119–127.

  • Minden A, Lin A, Clarel F-X, Abo A and Karin M. . 1995 Cell 81: 1147–1157.

  • Minn AJ, Vélez P, Schendel SL, Liang H, Muchmore SW, Fesik SW, Fill M and Thompson CB. . 1997 Nature 385: 353–357.

  • Miyashita T, Harigai M, Hanada M and Reed JC. . 1994a Cancer Res. 54: 3131–3135.

  • Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC. . 1994b Oncogene 9: 1799–1805.

  • Miyashita T and Reed JC. . 1995 Cell 80: 293–299.

  • Muraoka M, Konishi M, Yanoshita R, Tanaka K, Shitara N, Chong JM, Iwama T and Miyaki M. . 1996 Oncogene 12: 1565–1569.

  • Nagata S. . 1997 Cell 88: 355–365.

  • Oltvai ZN, Millman CL and Korsmeyer SJ. . 1993 Cell 74: 609–619.

  • Owen-Schaub L, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang W-W, Kruzel E and Radinsky R. . 1995 Mol. Cell. Biol. 15: 3032–3040.

  • Rossé T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B and Borner C. . 1998 Nature 391: 496–499.

  • Ruvolo PP, Deng X, Carr BK and May WS. . 1998 J. Biolog. Chem. 273: 25436–25442.

  • Sabbatini P, Chiou S-K, Rao L and White E. . 1995a Mol. Cell. Biol. 15: 1060–1070.

  • Sabbatini P, Ham JH, Chiou S-K, Nicholson D and White E. . 1997 Cell Growth Differ. 8: 643–653.

  • Sabbatini P, Lin J, Levine AJ and White E. . 1995b Genes Dev. 9: 2184–2192.

  • Sakamuro D, Sabbatini P, White E and Prendergast GC. . 1997 Oncogene 15: 887–898.

  • Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M, Yoon HS, Shuker SB, Chang BS, Minn AJ, Thompson CB and Fesik SW. . 1997 Science 275: 983–986.

  • Schendel SL, Azimov R, Pawlowski K, Godzik A, Kagan BL and Reed JC. . 1999 J. Biol. Chem. 274: 21932–21936.

  • Sells MA and Chernoff J. . 1997 Trends Cell Biol. 7: 162–167.

  • Symons M, Derry JMJ, Karlak B, Jiang S, Lemahieu V, McCormick F, Francke U and Abo A. . 1996 Cell 84: 723–734.

  • Tang Y, Chen Z, Ambrose D, Liu J, Gibbs JB, Chernoff J and Field J. . 1997 Mol. Cell. Biol. 17: 4454–4464.

  • Tapon N and Hall A. . 1997 Curr. Opin. Cell Biol. 9: 86–92.

  • Thomas A and White E. . 1998 Genes Dev. 12: 1975–1985.

  • Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA and Davis RJ. . 2000 Science 288: 870–873.

  • Van Aelst L and D'Souza-Schorey C. . 1997 Genes Dev. 11: 2295–2322.

  • Walter BN, Huang Z, Jakobi R, Tuazon PT, Alnemri ES, Litwack G and Traugh JA. . 1998 JBC 273: 28733–28739.

  • White E. . 1996 Genes Dev. 10: 1–15.

  • White E, Sabbatini P, Debbas M, Wold WSM, Kusher DI and Gooding L. . 1992 Mol. Cell. Biol. 12: 2570–2580.

  • Yamamoto K, Ichijo H and Korsmeyer SJ. . 1999 Mol. Cell. Biol. 19: 8469–8478.

  • Yang W and Cerione RA. . 1997 J. Biol. Chem. 222: 24819–24824.

  • Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH and Levine AJ. . 2000 Genes Dev. 14: 981–993.

  • Zhao ZS, Manser E, Chen X-Q, Chong C, Leung T and Lim L. . 1998 Mol. Cell. Biol. 18: 2153–2163.

Download references

Acknowledgements

We would like to thank Drs Alan Hall and Linda Van Aelst for cdc42 expression plasmids, Dr J Silvio Gutkind for JNK1 expression plasmid, Dr Celine Gelinas for Bcl-2 expression plasmid, and Dr Craig Thompson for Bcl-XL expression plasmid. Many thanks to Dr Andy Cuconati for making the dominant-negative PAK1 expression plasmid and all the other members of the White lab for thought-provoking discussions. This work was supported by NIH grant CA60088 and the Howard Hughes Medical Institute.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thomas, A., Giesler, T. & White, E. p53 mediates Bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway. Oncogene 19, 5259–5269 (2000). https://doi.org/10.1038/sj.onc.1203895

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203895

Keywords

This article is cited by

Search

Quick links